Raj Kedar, MD, chief of imaging, discusses how the hospital planned to continue operations last fall when faced with hurricanes Helene and Milton.
 

Michael Reardon, MD, detailed five-year data out of ACC.25 that found Medtronic's Evolut TAVR platform performs as well as SAVR—and even better in some ways. 

Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.

Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.

“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.

Erik Rockswold, director research and quality, Rayus Radiology, explains the administrative burdens radiology groups experience for little return from the Merit-Based Incentive Payment System.  

Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab."

Wes Folds, a PET specialist with the Intersocietal Accreditation Commission, discusses a new nuclear offering from IAC.